Bamco Inc Cytokinetics Inc Transaction History

Bamco Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$29.46 - $36.61 $441,900 - $549,150	-15,000 Reduced 37.5%	25,000 $736,000
Q2 2023 Aug 14, 2023	SELL	$32.62 - $40.75 $264,222 - $330,075	-8,100 Reduced 16.84%	40,000 $1.3 Million
Q1 2023 May 15, 2023	BUY	$33.36 - $45.71 $133,440 - $182,840	4,000 Added 9.07%	48,100 $1.69 Million
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $575,897 - $822,871	16,100 Added 57.5%	44,100 $2.02 Million
Q2 2022 Aug 15, 2022	SELL	$33.93 - $48.92 $339,300 - $489,200	-10,000 Reduced 26.32%	28,000 $1.1 Million
Q1 2022 May 13, 2022	SELL	$29.74 - $46.0 $297,400 - $460,000	-10,000 Reduced 20.83%	38,000 $1.4 Million
Q4 2021 Feb 14, 2022	BUY	$34.35 - $46.38 $1.65 Million - $2.23 Million	48,000 New	48,000 $2.19 Million

404

126M

3.24M

2.14M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.35B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

Stay updated on Bamco Inc with notifications on news.